Table 2.
Parameter | Comparison | Hazard ratio | 95% confidence interval | p value | β coefficient | Score |
---|---|---|---|---|---|---|
Aspartate transaminase ⩾ 31 IU/L |
⩾ versus < | 1.325 | 1.017–1.727 | 0.0374 | 0.281 | 2 |
Karnofsky Performance Score | ⩽ 80 versus ⩾ 90 | 1.395 | 1.078–1.806 | 0.0115 | 0.333 | 2 |
Derived neutrophil to lymphocyte ratio 2 | ⩾ versus < | 1.475 | 1.142–1.905 | 0.0029 | 0.388 | 3 |
Carbohydrate antigen 19-9 level (1000 U/L) | ⩾ versus < | 1.483 | 1.132–1.943 | 0.0042 | 0.394 | 3 |
Haemoglobin level (8.07 mmol/L) | < versus ⩾ | 1.514 | 1.163–1.973 | 0.0021 | 0.415 | 3 |
Presence of pain | Yes versus No | 1.564 | 1.185–2.064 | 0.0016 | 0.447 | 3 |
Distant metastases | Pre versus Abs | 1.604 | 1.164–2.211 | 0.0039 | 0.473 | 3 |
Alkaline phosphatase ⩾ 123 IU/L |
⩾ versus < | 1.653 | 1.220–2.241 | 0.0012 | 0.503 | 4 |
TOTAL SCORE | – | – | – | – | – | 0–23 |